Hankamer Group

Professor Ben Hankamer and Dr Melanie Oey examining petri dishes of algae

Growing tomorrow’s pharma in algae

Published on: 23 August 2021

Solar biotechnologies are being designed to expand Australian advanced manufacture, from next-generation COVID therapeutics through to renewable fuels.

The research could transform seaweed into new products such as medicines, food, nutraceuticals, nanomaterials and biofertilisers.

Oceans of opportunity for medicines, food and biofertiliser

Published on: 23 July 2021

Better medicines, food, nutraceuticals, nanomaterials and biofertilisers will flow from new Australian Government funding to bolster marine bioproduct innovation.

Bioinspired design of solar biotechnology systems

Our vision is to transform global industries with solar-driven biotechnologies that secure planetary sustainability and resilience.

Growing tomorrow’s pharma in algae

Oceans of opportunity for medicines, food and biofertiliser

Bioinspired design of solar biotechnology systems

Algae-based Biofertilisers

Recombinant proteins: Optimising downstream processing

Scaling up recombinant protein production in microalgae

Nanocellulose extraction from microalgae

Microalgae based burn therapeutics

Optimize microalgae production: High-throughput robotic screening

Construction of industrial enzyme production systems in microalgae

Pages

Research groups